[
    [
        {
            "time": "2018-10-30",
            "original_text": "After Hours Most Active for Oct 30, 2018: PX, FB, QQQ, FDC, XOG, MS, F, PFE, MFGP, ERIC, EGRX, EBAY",
            "features": {
                "keywords": [
                    "After Hours",
                    "Most Active",
                    "PX",
                    "FB",
                    "QQQ",
                    "FDC",
                    "XOG",
                    "MS",
                    "F",
                    "PFE",
                    "MFGP",
                    "ERIC",
                    "EGRX",
                    "EBAY"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "finance",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "After Hours Most Active for Oct 30, 2018: PX, FB, QQQ, FDC, XOG, MS, F, PFE, MFGP, ERIC, EGRX, EBAY",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-10-30",
            "original_text": "Is Beaten-Down Celgene Corporation a Buy Now?",
            "features": {
                "keywords": [
                    "Beaten-Down",
                    "Celgene Corporation",
                    "Buy"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Is Beaten-Down Celgene Corporation a Buy Now?",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-10-30",
            "original_text": "37% of Analysts Rate 3M as a ‘Buy’ after Its Q3 2018 Earnings",
            "features": {
                "keywords": [
                    "Analysts",
                    "3M",
                    "Buy",
                    "Q3 2018 Earnings"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "industrial goods"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "37% of Analysts Rate 3M as a ‘Buy’ after Its Q3 2018 Earnings",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-10-30",
            "original_text": "Validea Joel Greenblatt Strategy Daily Upgrade Report - 10/30/2018",
            "features": {
                "keywords": [
                    "Validea",
                    "Joel Greenblatt",
                    "Strategy",
                    "Daily Upgrade Report"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Validea Joel Greenblatt Strategy Daily Upgrade Report - 10/30/2018",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]